Historic PBS listing of cannabis for Dravet syndrome
Epidyolex for the treatment of Dravet syndrome, a rare and drug-resistant form of epilepsy. Manufactured by UK pharmaceutical company GW Pharmaceuticals, Epidyolex is a CBD product for children suffering from rare forms of epilepsy, such as Dravet syndrome and Lennox–Gastaut syndrome, which are resistant to conventional medications. Patients would usually pay more than $24,000 a […]